← peptides typeshit

Lilly raises sales guidance for the third time this year as Zepbound sales soar

Strong Zepbound demand pushed Eli Lilly to lift its outlook again, and the stock closed at a record high.

Read at MarketWatch

Recap by typeshit. Full story at MarketWatch.